---
figid: PMC3192015__nihms325485f1
figtitle: Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling
organisms:
- NA
pmcid: PMC3192015
filename: nihms325485f1.jpg
figlink: /pmc/articles/PMC3192015/figure/F1/
number: F1
caption: Signaling through a transmembrane receptor activates the PI3K signaling network
  to phosphorylate Akt and promote cell proliferation and invasion through mTOR. Multiple
  feedback loops exist within this signaling cascade, and a number of inhibitors are
  in development to target this pathway in cancer.
papertitle: Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase
  signaling.
reftext: Sumanta K. Pal, et al. J Thorac Oncol. ;5(12 Suppl 6):S487-S489.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9488916
figid_alias: PMC3192015__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3192015__F1
ndex: 2a5d6251-dec8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3192015__nihms325485f1.html
  '@type': Dataset
  description: Signaling through a transmembrane receptor activates the PI3K signaling
    network to phosphorylate Akt and promote cell proliferation and invasion through
    mTOR. Multiple feedback loops exist within this signaling cascade, and a number
    of inhibitors are in development to target this pathway in cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GlyRS
  - ras
  - Ras64B
  - Ras85D
  - IRSp53
  - IleRS
  - chico
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - SNF4Agamma
  - AMPKalpha
  - Dsor1
  - Mtk
  - Akt
  - Pdk1
  - gig
  - Erk7
  - rl
  - Rheb
  - S6kII
  - Crtc
  - Tor
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - rictor
  - PRAS40
  - raptor
  - ml
  - mi
  - stb
  - Vang
  - Thor
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - S6k
  - Myc
  - BCL2A1
  - KRAS
  - HRAS
  - NRAS
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - PDK1
  - PDPK1
  - TSC2
  - EPHB2
  - MAPK1
  - MAPK3
  - RHEB
  - RHEBP1
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - CRTC2
  - CRTC1
  - RICTOR
  - MLST8
  - AKT1S1
  - MTOR
  - RPTOR
  - EIF4EBP1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - MYC
  - perifosine
  - temsirolimus
  - PX-866
  - BEZ235
  - AZD8055
  - MK2206
  - rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
